Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

F. Tannock, Ian; de Wit, Ronald; R. Berry, William; Horti, J; Płużańska, A; N., Kim; Oudard, Stéphane; Théodore, Christine; D. James, Nicholas; Turesson, Ingela; Rosenthal, Mark; A. Eisenberger, Mario

doi:10.1056/nejmoa040720

Public

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

Published in New England Journal of Medicine • Oct 6, 2004

Authors:

Ian F. Tannock

Ronald de Wit

William R. Berry

Abstract

BACKGROUND: Mitoxantrone plus prednisone reduces pain and improves the quality of life in men with advanced, hormone-refractory prostate cancer, but it does not improve survival. We compared such treatment with docetaxel plus prednisone in men with this disease. METHODS: From March 2000 through June...

Subject

Prednisone

Mitoxantrone

Medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!